CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VCEL — Vericel Corp
CIK 884546
SAN FRANCISCO, CA
Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,601,498
+$7,291,023 QoQ
Shares Held
508,013
+6.7% QoQ
Ownership
0.992%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. VCEL ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,601,498 | 508,013 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,310,475 | 475,924 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,223,222 | 478,290 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,155,646 | 449,814 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,888,891 | 467,424 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,061,821 | 449,615 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $24,789,888 | 451,464 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $18,345,203 | 434,206 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,668,847 | 428,702 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,190,587 | 426,578 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $14,613,987 | 410,390 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $13,478,358 | 402,099 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,440,029 | 384,350 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $11,077,711 | 377,821 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,793,949 | 371,828 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,408,120 | 362,419 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,913,317 | 353,984 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,676,491 | 357,836 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,111,529 | 359,072 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $17,199,072 | 352,440 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $18,661,440 | 355,456 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $20,618,493 | 371,170 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,895,637 | 352,838 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,429,039 | 346,953 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,145,695 | 299,978 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $2,573,707 | 280,666 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||